Pharma News, 2019

The U.

SYDNEY (Reuters) - The Australian subsidiaries of British drugmaker GlaxoSmithKline and Swiss drugmaker Novartis misled customers and broke the law by promoting identical liniments as though t...

Studies in mice by researchers in Finland, Sweden, and Switzerland have shown how the most aggressive form of brain cancer, glioblastoma, can be stopped in its tracks by an antihistamine drug that tri...

(Reuters) - Johnson & Johnson said on Wednesday it expected to file marketing applications for at least 10 new drugs between 2019 to 2023, to strengthen its pharmaceuticals unit which has ...

(Reuters) - Pfizer Inc’s new atopic dermatitis treatment met the main goals in a late-stage study that tested the drug in patients aged 12 and older with moderate to severe forms of the dise...

B.

Thermo Fisher Scientific, which has been rapidly expanding its drug production, has yet another operation in its sights.

This $1 billion, 1-million-square-foot plasma fractionation plant in Georgia has gone through four owners already since it was envisioned.

China’s largest funder of basic science is piloting an artificial intelligence tool that selects researchers to review grant applications, in an attempt to make the process more efficient, faster an...

The US Food and Drug Administration (FDA) has approved Merck's Bavencio (avelumab) plus Inlyta (axitinib) combination for patients with advanced renal cell carcinoma.

Regeneron Pharmaceuticals, Inc.

Caveat emptor.